ArticleNucleic acids research2020

ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin.

Iris Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.